Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社, Chūgai Seiyaku kabushiki gaisha) is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014.[1] The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO.
This is a timeline of important events of Chugai Pharmaceutical.[2]
1925: Juzo Ueno founded Chugai Shinyaku Co. Ltd. and started importing and selling medicines
1927: Start of the first own production
1930: Salobrocanon, an analgesic (pain reliever ) and antipyretic, is launched
1937: Calcium bromide production begins
1943: Name changed to Chugai Pharmaceutical Co., Ltd. based in Tokyo
1944: Acquisition of Matsunaga Pharmaceutical Ltd. and construction of a plant in Matsunaga
1945: The headquarters, the factories in Ikebukuro, Sakai and Takada were destroyed in World War II, the headquarters were relocated to Takada, the factory in Takada was rebuilt
1946: Construction of the plant in Kamagiishi
1951: Guronsan, a drug to detoxify and restore liver function, is launched
1952: Varsan , a perspiration insecticide , is launched
1955: Chugai became a public company .
1956: The stock is listed on the Tokyo Stock Exchange
1957: Construction of the Ukima plant
1960: Establishment of a research center (Takada Research Laboratory, Tokyo)
1967: Foundation of Fukushima Kasai Co Ltd.
1961 – Developed patents for synthesis of vitamin A
1969: The name of Fukushima Kasai Co Ltd. is changed to Eiko Kasei Co Ltd . , after the merger of Fukushima Kasai Co Ltd. and Fukuma Kasau Co. Ltd.
1971: Construction of the factory in Fujieda
1975: Picibanil , a cancer drug, is launched
1982: Opening of a branch in New York
1986: Opening of a branch in London
1989: Acquisition of Gen-Probe Incorporated (USA)
1990: Epogin launched
1995 – Released acute promyelocytic sphere of leukemia drug treatment Vesanoid
2007: Copegus , an antiviral, Avastin , a cancer drug, and Tarceva , a cancer drug launched
2011 – Produced Actemra, a human IL-6 receptor monoclonal antibody for rheumatoid arthritis
2014: Launch of Kadcyla , a cancer drug, Chugai Pharma China Co Ltd. founded
2015 – In March the company announced it would co-commercialise Athersys's stem cell therapy for ischemic strokes in Japan. The deal could yield upwards of US$205 million.[3]
2016: Cooperation between Osaka University and Chugai
^Cortez, Michelle Fay; Matsuyama, Kanoko (25 August 2014). "Roche Said to Have Decided Against Bid for Rest of Chugai". Bloomberg.
^. 23 December 2015. Archived from the original on 1 November 2020. Retrieved 18 June 2019.
^Staff (2 March 2015). "Chugai to Co-Develop Athersys' Cell Therapy in Japan in Up-to-$205M Partnership". Genetic Engineering & Biotechnology News (Paper, Vol 35, i 7, p. 12). Retrieved 11 June 2016.
^"FDA Approves Treatment for Rare Disease Affecting Optic Nerves, Spinal Cord". U.S. Food and Drug Administration. 17 August 2020. Retrieved 18 August 2020.
External linksedit
Chugai Pharmaceutical Co., Ltd. English version of company homepage
Wikimedia Commons has media related to Chugai Pharmaceutical.
This article about a Japanese corporation- or company-related topic is a stub. You can help Wikipedia by expanding it.
chugai, pharmaceutical, 中外製薬株式会社, chūgai, seiyaku, kabushiki, gaisha, drug, manufacturer, operating, japan, subsidiary, controlled, hoffmann, roche, which, owns, company, june, 2014, company, headquartered, tokyo, osamu, nagayama, current, representative, dire. Chugai Pharmaceutical Co Ltd 中外製薬株式会社 Chugai Seiyaku kabushiki gaisha is a drug manufacturer operating in Japan It is a subsidiary controlled by Hoffmann La Roche which owns 62 of the company as of 30 June 2014 1 The company is headquartered in Tokyo Osamu Nagayama is the current representative director and chairman Tatsuro Kosaka is the current representative director president and CEO Chugai Pharmaceutical Co Ltd Headquarters in Nihonbashi Mitsui TowerNative name中外製薬株式会社Romanized nameChugai Seiyaku kabushiki gaishaCompany typePublic KKTraded asTYO 4519 Nikkei 225 componentIndustryPharmaceutical Industry Business import production and development of drugs for medical salesFoundedMarch 8 1943 81 years ago 1943 03 08 HeadquartersNihonbashi Mitsui Tower Nihonbashi Muromachi 2 1 1 Chuō Tokyo On the registration Headquarter Tokyo Kita Tokyo Key peopleOsamu Nagayama Chairman and Tatsuro Kosaka CEORevenue72 9 billion capital of 47 million yen Standalone sales of 329 2 billion yen and 344 8 billion yen consolidated December 2007 ParentHoffmann La Roche 61 62 Websitewww wbr chugai pharm wbr co wbr jp in Japanese Contents 1 History 1 1 Timeline 2 See also 3 References 4 External linksHistory editTimeline edit This is a timeline of important events of Chugai Pharmaceutical 2 1925 Juzo Ueno founded Chugai Shinyaku Co Ltd and started importing and selling medicines 1927 Start of the first own production 1930 Salobrocanon an analgesic pain reliever and antipyretic is launched 1937 Calcium bromide production begins 1943 Name changed to Chugai Pharmaceutical Co Ltd based in Tokyo 1944 Acquisition of Matsunaga Pharmaceutical Ltd and construction of a plant in Matsunaga 1945 The headquarters the factories in Ikebukuro Sakai and Takada were destroyed in World War II the headquarters were relocated to Takada the factory in Takada was rebuilt 1946 Construction of the plant in Kamagiishi 1951 Guronsan a drug to detoxify and restore liver function is launched 1952 Varsan a perspiration insecticide is launched 1955 Chugai became a public company 1956 The stock is listed on the Tokyo Stock Exchange 1957 Construction of the Ukima plant 1960 Establishment of a research center Takada Research Laboratory Tokyo 1967 Foundation of Fukushima Kasai Co Ltd 1961 Developed patents for synthesis of vitamin A 1969 The name of Fukushima Kasai Co Ltd is changed to Eiko Kasei Co Ltd after the merger of Fukushima Kasai Co Ltd and Fukuma Kasau Co Ltd 1971 Construction of the factory in Fujieda 1975 Picibanil a cancer drug is launched 1982 Opening of a branch in New York 1986 Opening of a branch in London 1989 Acquisition of Gen Probe Incorporated USA 1990 Epogin launched 1995 Released acute promyelocytic sphere of leukemia drug treatment Vesanoid 1996 Released anti viral chemotherapeutic agent Hivid HIV reverse transcriptase inhibitor 1997 Released HIV protease inhibitor Invirase 1999 Released immunosuppressive agent Cellcept 2000 Released antiemetic drug Kytril developed to combat the side effects of chemotherapy 2001 Produced anti influenza virus Tamiflu Roche 2002 Start of the alliance with Roche 2003 Xeloda a cancer drug is launched 2005 Actemra launched 2007 Copegus an antiviral Avastin a cancer drug and Tarceva a cancer drug launched 2011 Produced Actemra a human IL 6 receptor monoclonal antibody for rheumatoid arthritis 2014 Launch of Kadcyla a cancer drug Chugai Pharma China Co Ltd founded 2015 In March the company announced it would co commercialise Athersys s stem cell therapy for ischemic strokes in Japan The deal could yield upwards of US 205 million 3 2016 Cooperation between Osaka University and Chugai 2018 Tecentriq a cancer drug is launched 2020 FDA approved satralizumab Enspryng for treatment of the orphan disease neuromyelitis optica 4 See also editBiotech and pharmaceutical companies in the New York metropolitan areaReferences edit Cortez Michelle Fay Matsuyama Kanoko 25 August 2014 Roche Said to Have Decided Against Bid for Rest of Chugai Bloomberg History of Chugai Pharmaceutical 23 December 2015 Archived from the original on 1 November 2020 Retrieved 18 June 2019 Staff 2 March 2015 Chugai to Co Develop Athersys Cell Therapy in Japan in Up to 205M Partnership Genetic Engineering amp Biotechnology News Paper Vol 35 i 7 p 12 Retrieved 11 June 2016 FDA Approves Treatment for Rare Disease Affecting Optic Nerves Spinal Cord U S Food and Drug Administration 17 August 2020 Retrieved 18 August 2020 External links editChugai Pharmaceutical Co Ltd English version of company homepage nbsp Wikimedia Commons has media related to Chugai Pharmaceutical nbsp This article about a Japanese corporation or company related topic is a stub You can help Wikipedia by expanding it vte Retrieved from https en wikipedia org w index php title Chugai Pharmaceutical Co amp oldid 1217194247, wikipedia, wiki, book, books, library,
